| parent | Capreomycin | LP16787-1 |
| child | Capreomycin [Susceptibility] by Genotype method | 89483-2 |
| child | Capreomycin [Susceptibility] | 18872-2 |
| child | Capreomycin [Susceptibility] by Disk diffusion (KB) | 57-0 |
| child | Capreomycin [Susceptibility] by Gradient strip | 55623-3 |
| child | Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria | 23607-5 |
| child | Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | 56-2 |
| child | Capreomycin [Susceptibility] by Minimum lethal concentration (MLC) | 55-4 |
| child | Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | 25210-6 |
| child | Deprecated Capreomycin 10.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | 42643-7 |
| child | Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | 25211-4 |
| child | Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | 48170-5 |
| child | Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | 25212-2 |
| child | Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | 61355-4 |
| PartDisplayName | en-US | Capreomycin | Isolate | Antibiotic susceptibilities |
LOINC Version: 2.77
FHIR